Langer Robert
SEC-identified person · CIK 1239757 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Seer, Inc. SEER | Director | filed 2020–2025 |
| Moderna, Inc. MRNA | Director | filed 2018–2024 |
| Korro Bio, Inc. KRRO | Director | filed 2019–2022 |
| SQZ Biotechnologies Co SQZ | Officer | filed 2020–2020 |
| Lyra Therapeutics, Inc. LYRA | Director | filed 2020–2020 |
| Rubius Therapeutics, Inc. RUBY | Director | filed 2018–2019 |
| Kala Pharmaceuticals, Inc. KALA | Director | filed 2017–2018 |
| Abpro Corp ABP | Director | filed 2018–2018 |
| Dnib Unwind, INC. BIND | Director | filed 2013–2016 |
| Selecta Biosciences INC SELB | Officer | filed 2016–2016 |
| Ocata Therapeutics, Inc. OTCBB:ACTC | Director | filed 2012–2016 |
| Invivo Therapeutics Holdings Corp. None | Officer | filed 2010–2013 |
| Isolagen INC ILEIQ | Director | filed 2009–2011 |
| Millipore Corp /MA MIL | Director | filed 2009–2010 |
| Sontra Medical Corp SONTD | Director | filed 2006–2010 |
| Wyeth WYE | Director | filed 2006–2009 |
| Boston Life Sciences INC /DE BLSI | Director | filed 2006–2009 |
| Momenta Pharmaceuticals INC MNTA | Director | filed 2006–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.